Enterprise Value
79.03M
Cash
7.412M
Avg Qtr Burn
-19.43M
Short % of Float
2.53%
Insider Ownership
52.70%
Institutional Own.
29.38%
Qtr Updated
12/31/22
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Plenity Details Obesity | Approved Quarterly sales | |
Plenity Details Adolescent weight management in obesity | Phase 2 Data readout | |
GS200 Details Obesity, Diabetes, Type 2 diabetes | Phase 2 Update |